Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mi-Heon Lee"'
Autor:
Christine Nguyen, Anusha Kalbasi, Tahmineh Romero, James Sayre, J.P. Nesseler, Mi-Heon Lee, Dörthe Schaue, William H. McBride, Philippe Nickers
Publikováno v:
Cancers
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 714 (2020)
Cancers, vol 12, iss 3
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 714 (2020)
Cancers, vol 12, iss 3
The purpose of this study was to determine the dynamic contributions of different immune cell subsets to primary and abscopal tumor regression after hypofractionated radiation therapy (hRT) and the impact of anti-PD-1 therapy. A bilateral syngeneic F
Autor:
Li X. Zhu, Tonya C. Walser, Linh M. Tran, Kostyantyn Krysan, Michael C. Fishbein, Jerry W. Shay, Zhe Jing, Jill E. Larsen, Ying Q. Lin, Mi Heon Lee, Long sheng Hong, Steven M. Dubinett, John D. Minna, Sherven Sharma, Brigitte N. Gomperts, John A. Belperio, Aik Ooi, Natalie Yakobian, Gerald Wang
Publikováno v:
Cancer research, vol 78, iss 8
Epithelial-to-mesenchymal transition (EMT) is organized in cancer cells by a set of key transcription factors, but the significance of this process is still debated, including in non–small cell lung cancer (NSCLC). Here, we report increased express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abff79006384b38e02471c369fde37dd
https://europepmc.org/articles/PMC5899686/
https://europepmc.org/articles/PMC5899686/
Autor:
Christine Nguyen, Dörthe Schaue, William H. McBride, Ekambaram Ganapathy, Mi-Heon Lee, J.P. Nesseler
Publikováno v:
The British Journal of Radiology
The British journal of radiology, vol 90, iss 1078
The British journal of radiology, vol 90, iss 1078
The advent and success of immune checkpoint inhibitors (ICIs) in cancer treatment has broadened the spectrum of tumours that might be considered "immunogenic" and susceptible to immunotherapeutic (IT) intervention. Not all cancer types are sensitive,
Autor:
Eileen Fung, Kostyantyn Krysan, Jay M. Lee, Manash K. Paul, W. Dean Wallace, David Elashoff, Steven M. Dubinett, Michael C. Fishbein, Jane Yanagawa, Mi-Heon Lee, Rong Guo, John D. Minna
Publikováno v:
Clinical Cancer Research. 24:B20-B20
Background: Interferon-gamma (IFN-g) is known to play a pivotal role in PD-L1 expression and immune evasion in cancer cells, but there is little known regarding its interactions with premalignant lung lesions. Methods: Immortalized human bronchial ep
Autor:
John D. Minna, Gang Zeng, Steven M. Dubinett, Sherven Sharma, Jay M. Lee, Jonathan W. Goldman, Boning Gao, Tonya C. Walser, Mi-Heon Lee, Jane Yanagawa, Edward B. Garon
Publikováno v:
Cancer Research. 76:2324-2324
BACKGROUND: Activating KRAS mutations are common driver mutations in non-small cell lung carcinoma. Patients with mutated KRAS demonstrate less benefit from adjuvant chemotherapy and resistance to tyrosine kinase inhibitors. KRAS mutations are known